ATRA Earnings Atara Biotherapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.29 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | 2.57 | 2026-03-16 | 10-K |
| Q3 2025 | 2025-09-30 | 2.93 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | 3.49 | 2025-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | 3.50 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -11.41 | 2026-03-16 | 10-K |
| Q3 2025 | 2024-09-30 | -11.34 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -8.64 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -5.65 | 2025-05-15 | 10-Q |
| FY 2024 | 2023-12-31 | -65.19 | 2025-03-07 | 10-K |
| Q3 2024 | 2023-09-30 | -51.27 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -34.89 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.72 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -2.24 | 2024-03-28 | 10-K |
| Q3 2023 | 2022-09-30 | -1.51 | 2023-11-01 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.69 | 2023-08-08 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.87 | 2023-05-08 | 10-Q |
| FY 2022 | 2021-12-31 | -3.63 | 2023-02-08 | 10-K |
| Q3 2022 | 2021-09-30 | -2.67 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.77 | 2022-08-08 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.